NEW! Publication on neurocognition and social cognition in patients with schizophrenia spectrum disorders with and without a history of violence

Category: News

We are pleased to announce that an article by the EU-VIORMED group has been published in Translational Psychiatry (2021 Impact Factor: 6.3) on Dec 8, 2021.

Neurocognitive impairment has been extensively studied in people with schizophrenia spectrum disorders and seems to be one of the major determinants of functional outcome in this clinical population. Data exploring the link between neuropsychological deficits and the risk of violence in schizophrenia has been more inconsistent. In this study, we analyse the differential predictive potential of neurocognition and social cognition to discriminate patients with schizophrenia spectrum disorders with and without a history of severe violence.

Download the article

The article is available also as online content, please see https://doi.org/10.1038/s41398-021-01749-1

Read more news...